Home › Funds › TANG CAPITAL MANAGEMENT LLC › ANAB

TANG CAPITAL MANAGEMENT LLC position in ANAB

ANAPTYSBIO INC COM · Health Care

TANG CAPITAL MANAGEMENT LLC reported holding 1,330,879 shares of ANAB (ANAPTYSBIO INC COM) in its Q2 2026 13F filing — a position valued at US$89.8M, representing 4.08% of its reported portfolio and ranking #12 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed ANAB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.33M sh
Reported value held$89.83M
Portfolio Weight4.08%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TANG CAPITAL MANAGEMENT LLC's ANAB position evolved

TANG CAPITAL MANAGEMENT LLC first disclosed a stake in ANAB in Q3 2023 at 1,950,609 shares (US$35.0M). The position peaked in Q2 2026 at 1,330,879 shares, worth US$89.8M. Across 12 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 1,330,879 shares valued at US$89.8M. Notable position changes include a 32% trim in Q1 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.95M $35.03M New
Q4 2023 1.95M $41.78M Hold
Q1 2024 1.33M $29.97M Reduce
Q2 2024 1.33M $33.35M Hold
Q3 2024 1.33M $44.58M Hold
Q4 2024 1.33M $17.62M Hold
Q1 2025 1.55M $28.72M Add
Q2 2025 1.33M $29.55M Reduce
Q3 2025 1.33M $40.84M Hold
Q4 2025 1.33M $64.58M Hold
Q1 2026 1.33M $73.81M Hold
Q2 2026 1.33M $89.83M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANAB and 13F data

ANAB (ANAPTYSBIO INC COM) is a Health Care company. 46 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$531.9M), Affinity Asset Advisors, LLC (US$55.8M), Sanofi (US$55.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANAB

All ANAB fund holders →

FAQ

How long has TANG CAPITAL MANAGEMENT LLC held ANAB?

TANG CAPITAL MANAGEMENT LLC has disclosed ANAB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TANG CAPITAL MANAGEMENT LLC's current position in ANAB?

As of Q2 2026, TANG CAPITAL MANAGEMENT LLC holds 1.33M shares of ANAB (ANAPTYSBIO INC COM), valued at $89.83M, representing 4.08% of its reported portfolio and ranking #12.

Has TANG CAPITAL MANAGEMENT LLC been buying or selling ANAB?

In the latest 13F filing (Q2 2026), TANG CAPITAL MANAGEMENT LLC held unchanged its position in ANAB. The position peaked in Q2 2026 at 1.33M shares.

Which other funds hold ANAB?

Other major institutional holders of ANAB include EcoR1 Capital, LLC, Affinity Asset Advisors, LLC, Sanofi, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.